Search Results for: "Continuity Planning"

Showing 2,071 - 2,080 of 2,196 results

CMS Expands Site-Neutral Payment Policy in CY 2019 OPPS Final Rule

This post has been archived and contains information that may be out of date.

Today, the Centers for Medicare & Medicaid Services (CMS) issued its final rule updating the outpatient prospective payment system (OPPS) for calendar year (CY) 2019, which also includes payment updates for ambulatory surgical centers. Despite strong opposition from CHA and the hospital field, CMS finalized an expansion of its site-neutral payment policies.

Coronavirus Response Newsletter

This post has been archived and contains information that may be out of date.

Urgent Steps Hospitals Should Take If Nurse Staffing Ratio Waivers Are Still Needed

CHA has been advised by the California Department of Public Health (CDPH) of the steps that hospitals must take to maintain any needed staffing waivers. As a reminder, all existing approved COVID-19 staffing-related waivers end at 11:59 p.m. on Feb. 8 (per All Facilities Letter (AFL) 20-26.6). Hospitals that do not have enough staff to meet the standard ratios are encouraged to take these steps immediately, if they have not already.

HQI to Host Webinar on Breastfeeding and Perinatal Mental Health

This post has been archived and contains information that may be out of date.

This post has been archived and contains information that may be out of date.As part of its Perinatal Mental Health (PMH) Learning Community, the Hospital Quality Institute (HQI) will host a free webinar on Oct. 21 from noon to 1 p.m. (PT) on breastfeeding and perinatal mental health.   The webinar, which will be led by perinatal health and mental health advocate and consultant Nakeisha Robinson, MA, LMFT, will discuss the role that breast/chestfeeding plays in perinatal mental health and identify ways to […]

Coronavirus Response Newsletter

This post has been archived and contains information that may be out of date.

Update on Monoclonal Antibody Therapy Authorized for Emergency Use
On Nov. 9, the Food and Drug Administration granted emergency use authorization (EUA) to a monoclonal antibody therapy called bamlanivimab, produced by Eli Lilly and Company, for the treatment of mild to moderate COVID-19. The federal government has purchased 320,000 doses through the end of 2020; the first allocation to California will be 4,040 doses. California is expected to receive allocations each week.

Learn from Your Peers During Zoom Session On Reopening Gift Shops

This post has been archived and contains information that may be out of date.

Learn from Your Peers – Reopening Your Gift Shops During COVID session took place Dec. 15 from 2 to 3 p.m.  Thank you to presenters Gina Cuneo with Enloe Medical Center, Mamta Kaur with Stanford Health Care, and Stephanie Nelson with Ventura County Medical Center for providing an excellent educational session for our members. 

Licensing and Telehealth Waivers Webinar

This post has been archived and contains information that may be out of date.

Originally recorded on January 13, 2021

Recording

[embed]

Overview

State and federal agencies have issued many waivers granting hospitals and health care providers flexibility in complying with payment and other requirements during the COVID-19 pandemic.